0001437749-20-025282.txt : 20201214 0001437749-20-025282.hdr.sgml : 20201214 20201214160224 ACCESSION NUMBER: 0001437749-20-025282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201211 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FINE N SCOTT CENTRAL INDEX KEY: 0001163556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39780 FILM NUMBER: 201386166 MAIL ADDRESS: STREET 1: 600 3RD AVE CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc. CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6714 NW 16TH STREET, SUITE B CITY: GAINSVILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: PO BOX 1180 CITY: ALACHUA STATE: FL ZIP: 32616-1180 FORMER COMPANY: FORMER CONFORMED NAME: CTD HOLDINGS INC DATE OF NAME CHANGE: 20000913 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 4 1 rdgdoc.xml FORM 4 X0306 4 2020-12-11 0000922247 Cyclo Therapeutics, Inc. CYTH 0001163556 FINE N SCOTT 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32163 1 1 Chief Executive Officer Common Stock 2020-12-11 4 P 0 20000 A 99666 D Warrant to Purchase Common Stock 5 2020-12-11 4 P 0 20000 A 2020-12-11 2025-12-11 Common Stock 20000 20000 D The reported securities consist of 20,000 "Units" purchased by the reporting person for $5.00 per Unit. Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock. /s/ N. Scott Fine 2020-12-14